A detailed history of Ensign Peak Advisors, Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 1,682,997 shares of BSX stock, worth $151 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
1,682,997
Previous 1,847,392 8.9%
Holding current value
$151 Million
Previous $142 Million 0.87%
% of portfolio
0.25%
Previous 0.26%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$72.96 - $84.0 $12 Million - $13.8 Million
-164,395 Reduced 8.9%
1,682,997 $141 Million
Q2 2024

Aug 13, 2024

SELL
$67.33 - $77.71 $25.6 Million - $29.6 Million
-380,423 Reduced 17.08%
1,847,392 $142 Million
Q1 2024

May 14, 2024

BUY
$57.6 - $68.62 $16.9 Million - $20.2 Million
294,081 Added 15.21%
2,227,815 $153 Million
Q4 2023

Feb 14, 2024

BUY
$48.64 - $57.81 $3.64 Million - $4.32 Million
74,773 Added 4.02%
1,933,734 $112 Million
Q3 2023

Nov 13, 2023

BUY
$50.19 - $54.68 $20.2 Million - $22 Million
401,718 Added 27.57%
1,858,961 $98.2 Million
Q2 2023

Aug 14, 2023

SELL
$49.72 - $54.64 $10.3 Million - $11.3 Million
-206,574 Reduced 12.42%
1,457,243 $78.8 Million
Q1 2023

May 15, 2023

SELL
$45.09 - $50.03 $7.93 Million - $8.8 Million
-175,908 Reduced 9.56%
1,663,817 $83.2 Million
Q4 2022

Feb 13, 2023

BUY
$39.56 - $47.22 $1.68 Million - $2 Million
42,379 Added 2.36%
1,839,725 $85.1 Million
Q3 2022

Nov 14, 2022

SELL
$36.71 - $109.66 $5.31 Million - $15.9 Million
-144,633 Reduced 7.45%
1,797,346 $69.6 Million
Q2 2022

Aug 12, 2022

BUY
$35.24 - $47.1 $2.97 Million - $3.96 Million
84,173 Added 4.53%
1,941,979 $72.4 Million
Q1 2022

May 16, 2022

SELL
$40.9 - $45.1 $2.65 Million - $2.93 Million
-64,901 Reduced 3.38%
1,857,806 $82.3 Million
Q4 2021

Feb 11, 2022

BUY
$38.07 - $44.87 $3.21 Million - $3.79 Million
84,414 Added 4.59%
1,922,707 $81.7 Million
Q3 2021

Nov 12, 2021

BUY
$41.23 - $45.88 $27.2 Million - $30.3 Million
659,331 Added 55.92%
1,838,293 $79.8 Million
Q2 2021

Aug 13, 2021

SELL
$38.58 - $44.24 $468,206 - $536,896
-12,136 Reduced 1.02%
1,178,962 $50.4 Million
Q1 2021

May 12, 2021

BUY
$35.27 - $39.67 $4.03 Million - $4.53 Million
114,288 Added 10.61%
1,191,098 $46 Million
Q4 2020

Feb 12, 2021

BUY
$33.15 - $41.97 $28.1 Million - $35.5 Million
846,454 Added 367.45%
1,076,810 $38.7 Million
Q3 2020

Nov 12, 2020

BUY
$34.44 - $42.23 $996,452 - $1.22 Million
28,933 Added 14.36%
230,356 $8.8 Million
Q2 2020

Aug 12, 2020

SELL
$30.19 - $39.11 $1.6 Million - $2.07 Million
-53,010 Reduced 20.83%
201,423 $7.07 Million
Q1 2020

May 11, 2020

SELL
$25.83 - $45.71 $6.56 Million - $11.6 Million
-254,149 Reduced 49.97%
254,433 $8.3 Million
Q4 2019

Feb 14, 2020

BUY
$37.87 - $45.37 $19.3 Million - $23.1 Million
508,582 New
508,582 $23 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.